CCL20 and breast carcinoma: In addition, CCL20 markedly increased cell migration and invasion and the activities of related proteases in basal-like/triple-negative breast cancer cell lines but not in luminal breast cancer cell lines, suggesting that the targeting of CCL20 may be more effective in patients with aggressive breast cancer.